SPONSORED CONTENT
Trademark registration service includes:
- Trademark attorney managed
- Federal trademark search
- Apply online - fast & easy
- Electronic filing of application
- You are always kept informed
By: Idorsia Pharmaceuticals Ltd
Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and ...
Status Alert: On Wednesday, February 18, 2026, the status for the JOFABYO mark changed to NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER .
|
On Wednesday, February 18, 2026, a U.S federal trademark application was filed for JOFABYO by Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil. The USPTO has assigned the JOFABYO mark the serial number 99659652. The JOFABYO mark has been filed in the category Pharmaceutical Products. The owner of the JOFABYO mark is listed as Idorsia Pharmaceuticals Ltd, Hegenheimermattweg 91, Allschwil. The correspondent for the JOFABYO mark is CORY POKER HOXIE & ASSOCIATES LLC of 75 MAIN STREET, SUITE 203, MILLBURN, NJ 07041, UNITED STATES. If you have licensing, usage or other questions concerning the JOFABYO mark, please contact the owner through the listed correspondent. The description provided for the JOFABYO mark is Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and ... |
|
| Word Mark: | JOFABYO |
| Status: | NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date: | 02/18/2026 |
| Serial Number: | 99659652 |
| Filing Date: | 02/18/2026 |
| Registration Number: | Not Available |
| Registration Date: | Not Available |
| Goods and Services: | Pharmaceutical preparations for the treatment of cardiovascular and pulmonary diseases, inflammatory diseases, cancer, auto-immune disorders, neurodegenerative diseases, neurological disorders, anxiety, addictions including addictive eating disorders, neurodegenerative disorders including Alzheimer's disease, diseases of the central nervous system, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, and allergic diseases; Pharmaceutical preparations for the treatment of hypertension, diabetes, and kidney diseases, including chronic kidney disease, diabetic kidney disease, and kidney diseases associated with glycolipid storage disorders and Fabry disease |
| Type Of Mark: | Trademark |
| Register Type: | Principal |
| Published For Opposition Date: | Not Available |
| Current Owner: | Idorsia Pharmaceuticals Ltd Hegenheimermattweg 91 Allschwil CH-4123 SWITZERLAND |
| Mark Description: | Not Available |
| Mark Drawing Type: | Not Available |
| Design Search: | Not Available |
| Disclaimer: | Not Available |
| Correspondent: | CORY POKER HOXIE & ASSOCIATES LLC 75 MAIN STREET SUITE 203 MILLBURN, NJ 07041 UNITED STATES |
| International Class(es): | 005 |
| US Class(es): | 005, 006, 018, 044, 046, 051, 052 |
| Primary Class: | Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| Class(es) Status: | Active |
| First Use Anywhere: | Not Available |
| First Use In Commerce: | Not Available |
| Retrieve Trademark Documents |